ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,198.78
0.53%
Dow Jones
40,415.44
0.32%
Gold vs US Dollar
2,396.58
0.02%
Brent Oil
81.545
0.04%
Bitcoin
67,731.73
0.19%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Uniqure NV (UQ1) Share Price

UQ1 Uniqure NV

7.004
-0.116 (-1.63%)
22 Jul 2024 - Closed
Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Uniqure NV TG:UQ1 Tradegate (DE) Ordinary Share NL0010696654 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   -0.116 -1.63 7.004 6.956 7.034 6.952 6.802 6.952 2,025 21:50:13   
 Type  Size  Price  Time  Units 
  85 6.93 14:26:37 EUR
 
Recent News
DateTimeSource
HeadlineMore UQ1 News
09/07/202412:05UKREGuniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
01/07/202412:05GLOBEuniQure Announces Sale of Commercial Manufacturing Facility to Genezen
03/06/202412:05GLOBEuniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
07/05/202412:05GLOBEuniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
28/02/202412:05GLOBEuniQure Announces 2023 Financial Results and Highlights Recent Company Progress
19/12/202312:05GLOBEuniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
08/12/202312:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Period
Draw mode
Data Downloads for UQ1

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Uniqure NV Articles